Despite strong financial headwinds, venture capital (VC) firms continue to provide biotech startups with the critical cash they need to develop and scale...
As the COVID-19 pandemic fades, we may debate whether public health responses could have been better. But first we need to understand what public health...
Something called “immunity debt” has been in the news quite a bit lately. Most recently, because of what looks like a multicountry Mycoplasma pneumoniae...
The Unexpected Battle Between Vaccines And The COVID Virus Authored by Yuhong Dong via The Epoch Times (emphasis ours), Since the unprecedented...
Certain COVID-19 Vaccines Linked To Elevated Risk Of Guillain-Barré Syndrome Authored by Ellen Wan via The Epoch Times (emphasis ours), As...
November 9, 2023, SEOUL, Republic of Korea and BANDUNG, Indonesia — The International Vaccine Institute (IVI), an international organization with a mission...
Novavax, which has been reeling from a slow rollout of its Covid-19 vaccine compared to the mRNA makers, said it will once again cut costs. Like...
An international effort to create yeast cells with a fully synthetic genome is nearing completion, with the eventual aim of unraveling the mysteries of...
Billions Of Copies Of Residual DNA In A Single Dose Of COVID-19 mRNA Vaccine: Preprint Authored by Marina Zhang via The Epoch Times (emphasis...
Moderna is turning its Covid-19 vaccine brand name Spikevax into a verb in its first ad campaign. The debut TV ad — which includes an upbeat...
The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019. Since then, extensive efforts...
Bioregnum Opinion Column by John Carroll Flagship Pioneering is staking out a new home base in Asia, recruiting a longtime McKinsey vet — and a colleague...
"The Big Fail" - Anti-Lockdown Goes Mainstream Authored by Jeffrey Tucker via The Brownstone Institute, It’s a shift worth marking. New...
As BioNTech continues to beef up its oncology pipeline, it’s once again turning to a Chinese partner. The German biotech is putting down $55 million...
The Great Reset, Part 2: A Camp With No Outside Authored by Simon Elmer via Off-Guardian.org, ‘Today, it is not the city but rather the...
FDA Responds After Being Urged To Recall Pfizer's Vaccine Over DNA Fragments Authored by Zachary Stieber via The Epoch Times (emphasis ours), The...
FBI = Following Biden's Instructions? Authored by James Bovard via JimBovard.com, Does “FBI” now stand for “Following Biden’s Instructions”?...
Discover how Lonza’s early process engagement can help deliver efficient, cost-effective production. The post Insights into mRNA Scale-Up and cGMP Manufacturing...
Certain Scientists, Journals Pose 'Potential Threats To Vaccine Confidence': CDC Authored by Zachary Stieber via The Epoch Times (emphasis...
BioNTech, the German drug company famous for developing a Covid-19 vaccine with Pfizer, has acquired AexeRNA and its novel lipid nanoparticles for mRNA...
The Covid boom is over at Moderna. On Thursday, the biotech said it was bracing for sales to “hit a low point” in 2024 as demand...
Your doctor’s MD emerged from the Dark Ages, where practicing rational “human medicine” was seen as an expression of faith and maintaining one’s...
PHILADELPHIA—(Nov. 1, 2023)—The Wistar Institute’s David B. Weiner, Ph.D., executive vice president, director of the Vaccine & Immunotherapy...
Pfizer To Shut Down Two Facilities Amid Major Cost Cuts Authored by Jack Phillips via The Epoch Times (emphasis ours), Pharmaceutical giant...
PHILADELPHIA – Americans have less confidence in vaccines to address a variety of illnesses than they did just a year or two ago, and more people...
GSK’s RSV vaccine Arexvy got off to a strong start in its first full quarter post-launch, the company revealed during its third-quarter earnings. It...
GSK’s RSV vaccine Arexvy got off to a strong start in its first full quarter post-launch, the company revealed during its third-quarter earnings. It...
Recent preclinical results indicate novel next-generation vaccine candidates developed at Cleveland Clinic protect against multiple strains of influenza...
Pfizer is culling a handful of clinical programs, including trials in cancer and dermatology, it announced Tuesday. The cuts include two Phase II programs,...
British drugmaker GSK plans to acquire an experimental hepatitis B drug from Johnson & Johnson and its developer Arrowhead Pharmaceuticals and then...